The study population will include ten patients (ages 18-60 yrs) with confirmed mutations of the iron-sulfur cluster biogenesis complex of proteins and experiencing dyspnea, heart failure, or exercise intolerance. It will also include ten additional patients (ages 18-60 yrs) who are unaffected first-degree family members of the above subjects.